The statistic is startling: More than two million people become ill with antibiotic-resistant infections each year. Many of these organisms are the cause of healthcare-associated infections (HAIs), which impact one in 25 patients in the U.S. annually. These infections claim the lives of 75,000 people and cost the healthcare industry between $36-$45 billion each year.
If you don’t fully grasp just how dangerous these infections are, read the next sentence. MRSA and CRE, two antibiotic-resistant infections that have received a lot of attention due to recent outbreaks have exceptionally high mortality rates – 20 percent and 50 percent, respectively.
Organizations across healthcare are looking for new ways to further drive down the rate of these preventable infections. While hospitals are broadening their infection-prevention strategies, med-device manufacturers are looking to incorporate design features, most notably antimicrobial additives, to the surface of their products to help combat the problem.
With the demand for antimicrobial-protected medical devices growing, manufacturers are exploring how they can develop new technologies to meet the needs of their customers. Yet they are often left with many unanswered questions with regard to antimicrobial additives. There is certainly a lot of confusion in the market.
In response to this, Lise Moloney, Sciessent’s director of business development, healthcare, created an informational guide for med-device companies looking to incorporate antimicrobials into their products. This is the first resource of its kind – answering all of the major questions that have plagued (and potentially held back) med-device manufacturers from fully embracing antimicrobial functionality.